Detected ·
RevvoMed Innovations AB
SEK 7M—
RevvoMed Innovations AB raised SEK 7 million in an early funding round, with investors Johan Staël von Holstein and Erik Wikström, to develop its membrane protein platform for precision cancer drugs.
- Website
- www.revvomed.com
- linkedin.com/company/144948938
- Amount
- kr 7 000 000 SEK
- Stage
- —
- Event
- Funding round
- Detected
- 2026-11-04 04:10:17 UTC
- Signal ID
- 970b75c0-b198-4329-b1f5-1a65fda48f60
As the API returns it
{
"id": "970b75c0-b198-4329-b1f5-1a65fda48f60",
"created_at": "2026-11-04T04:10:17.717468Z",
"company_name": "RevvoMed Innovations AB",
"company_website_url": "www.revvomed.com",
"company_linkedin_url": "https://www.linkedin.com/company/144948938",
"event_type": "funding",
"funding_amount": 7000000,
"funding_currency": "SEK",
"funding_stage": null,
"message": "*RevvoMed Innovations AB raised SEK 7 million in an early funding round, with investors Johan Staël von Holstein and Erik Wikström, to develop its membrane protein platform for precision cancer drugs.*"
}